Drug comparisons
Repaglinide vs Troglitazone
Repaglinide stimulates insulin release, Troglitazone improves sensitivity. Troglitazone withdrawn for liver toxicity, Repaglinide is current option.
No comparison dimensions are available for this page.
Clinical context
Individuals with type 2 diabetes who are considering treatment options may compare Repaglinide and Troglitazone to understand their respective roles in blood glucose management.
Bottom line
Repaglinide is the preferred current option compared to Troglitazone, which has been withdrawn due to safety concerns.
All medication comparisons